CARCINOMA, RENAL CELL
Clinical trials for CARCINOMA, RENAL CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, RENAL CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, RENAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Kidney cancer drug combo trial halted early: what it means for patients
Disease control TerminatedThis study looked at adding atezolizumab (an immunotherapy) to cabozantinib (a targeted therapy) for people with advanced kidney cancer that got worse after prior immunotherapy. The goal was to see if the combination worked better than cabozantinib alone. The trial was terminated…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
New drug cocktail for advanced kidney cancer shows early promise, but trial halted
Disease control TerminatedThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was …
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Experimental cancer drug SGI-110 tested in rare tumors – study halted early
Disease control TerminatedThis study tested the drug SGI-110 in people aged 12 and older with rare cancers like wild-type GIST, pheochromocytoma, paraganglioma, or HLRCC kidney cancer that had not responded to other treatments. The goal was to see if the drug could shrink tumors or slow their growth. The …
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-phase study tested an experimental drug called QEQ278 in 30 adults with advanced solid tumors, including lung, kidney, esophageal, and head and neck cancers. The main goal was to check the drug's safety and find the right dose. The trial was terminated early, so result…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New drug combo targets Hard-to-Treat kidney cancer
Disease control TerminatedThis early-stage study tested a new drug called DFF332 in people with advanced clear cell kidney cancer. The drug works by blocking a protein (HIF2α) that helps some cancers grow. Researchers gave DFF332 alone or with other drugs to see if it was safe and could shrink tumors. The…
Matched conditions: CARCINOMA, RENAL CELL
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 12:13 UTC